The board of directors of Vicore Pharma has resolved, subject to the approval by an extraordinary general meeting, on a directed new issue of shares, whereby Vicore Pharma will raise proceeds of approximately SEK 160 million before issue costs.
Aprea Therapeutics AB, with headquarters in Stockholm (Solna), is a biotechnology company focused on the discovery and development of new cancer drugs reactivating the tumour suppressor protein p53.
Vinge has advised Swedavia Real Estate AB’s and Alecta pensionsförsäkring ömsesidigt’s jointly-owned joint venture company Swedish Airport Infrastructure KB and its subsidiary in connection with a restructuring of the group and a SEK 3.7 billion refinancing.
Vinge has advised CELLINK AB, listed on First North Stockholm, in connection with the acquisition of all shares in Dispendix GmbH. Dispendix’s operations focus on bio dispensing technology and its patented technology emanates from a 10-year development within the German research institute Fraunhofer.
Vinge has assisted Vostok New Ventures Ltd (“Vostok”) in connection with an investment by a number of investors in Voi Technology AB, a company that provides an electric scooter sharing service.
Vinge has advised the newly-formed company Gotoga, where the ownership structure consists of the existing majority owner in Whyred, in conjunction with its acquisition of the Swedish parent company Hope
Wassum and Söderberg & Partners have merged and formed Wassum/Söderberg & Partners Institutional Advisors within the field of advice to institutional investors.
The board of directors of Hansa Medical has resolved on a directed new issue of shares, whereby Hansa Medical will raise proceeds of approximately SEK 453 / USD 50 million, before issue costs.
On 25 April 2017 the European Commission conducted dawnraids at the premises of Tele2 and three other mobile network operators active in Sweden regarding potential infringements of EU competition law.
Vinge has represented Adelis in connection with Presto Brandsäkerhet and Aptum joining forces to become the leading player in fire safety in the Nordic region with revenue of more than SEK 700 million.
Vinge has advised Irisity AB (publ), Nasdaq First North, in connection with a directed new issue of shares to Nordic institutional and private investors.
